Search results :

Cysteamine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: A16AA04

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5
Body temperature increased Body temperature increased very common, 22% - 28% x x x x
Vomiting Vomiting very common, 12% - 35% x x x x
Diarrhoea Diarrhoea postmarketing — 16% - 31% x x x x
Decreased appetite Anorexia very common, 2% - 33% x x x x
Appetite absent 2% - 5% x
Decreased appetite x
Lethargy Lethargy very common, 11% - 17% x x x x
Nausea Nausea very common, 7% - 16% x x x x
Discomfort Discomfort 0% - 14% x
Dermatitis Rash common, 7% x x x x
Rash Rash common, 7% x x x x
Asthenia Asthenia common x x
Fatigue x
Dyspepsia Dyspepsia common x x x
Gastroenteritis Gastroenteritis common x x x
Breath odour Breath odour common x x x x
Headache Headache common, 0% - 9% x x x x x
Encephalopathy Encephalopathy common x x x x
Liver function test abnormal Liver function test abnormal common x x
Skin odour abnormal Skin odour abnormal common x x
Abdominal pain Abdominal pain postmarketing — 0% - 14% x x x x
Gastrointestinal pain Abdominal pain postmarketing — 0% - 14% x x x x
Dizziness Dizziness 0% - 5% x x
Anaphylactic shock Anaphylactic shock uncommon x x x
Hallucination Hallucination uncommon x x x
Leukopenia Leukopenia uncommon x x x x
Nephrotic syndrome Nephrotic syndrome uncommon x x
Nervousness Nervousness uncommon x x x
Feeling jittery x
Tension Nervousness uncommon x x x
Convulsion Convulsion uncommon x x x x
Gastrointestinal ulcer Gastrointestinal ulcer uncommon x x
Hair colour changes Hair colour changes uncommon x x
Somnolence Somnolence uncommon x x x x
Gastrointestinal disorder Gastrointestinal disorder postmarketing x x x
Pain in extremity Leg pain postmarketing, uncommon x x x x
Osteopenia Osteopenia postmarketing, uncommon x x x x
Optic neuritis Papilloedema postmarketing x x x
Papilloedema Papilloedema postmarketing x x x
Mass Pseudotumor postmarketing, uncommon x x x x
Benign intracranial hypertension Benign intracranial hypertension postmarketing x x x
Scoliosis Scoliosis postmarketing, uncommon x x x x
Skin striae Skin striae postmarketing, uncommon x x x x
Joint hyperextension Joint hyperextension postmarketing, uncommon x x x x
Compression fracture Compression fracture postmarketing, uncommon x x x x
Skin fragility Skin fragility postmarketing, uncommon x x x
Knee deformity Genu valgum postmarketing, uncommon x x x x
Anaemia Anaemia x
Ataxia Ataxia x
Mental disorder Mental disorder x x
Bone disorder Bone disorder x x
Confusional state Confusional state x
Feeling abnormal Confusional state x
Connective tissue disorder Connective tissue disorder x
Constipation Constipation x
Dehydration Dehydration x
Duodenitis Duodenitis x
Fatigue Fatigue x
Glomerulonephritis membranous Glomerulonephritis membranous x x
Hypersensitivity Hypersensitivity x x x
Hypertension Hypertension x
Immune system disorder Immune system disorder x x
Tubulointerstitial nephritis Nephritis interstitial x x x x
Nervous system disorder Nervous system disorder x x
Nightmare Nightmare x
Renal failure Renal failure x
Scotoma Scotoma x
Tremor Tremor x
Urethral disorder Urinary tract disorder x x
Urinary tract disorder Urinary tract disorder x x
Urticaria Urticaria x x
Mood swings Mood swings x
Affect lability Mood swings x
Hepatic function abnormal Hepatic function abnormal x
Eye pain Eye pain x
Blood alkaline phosphatase increased Phosphatase alkaline increased x
Malnutrition Malnutrition x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x x
Thinking abnormal Thinking abnormal x
Mental disability Thinking abnormal x
Bone lesion Bone lesion x x
Urine odour abnormal Urine odour abnormal x
Erythema Redness x
Diffuse large B-cell lymphoma Intravascular large B-cell lymphoma x x
Agitation Hyperkinesia x
Hyperkinesia Hyperkinesia x
Feeling jittery Feeling jittery x
Cerebral ischaemia Cerebral ischaemia x x
Gastrointestinal ulcer haemorrhage Gastrointestinal ulcer haemorrhage x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CYSTEAMINE

Side effects:4
Source:FDA Structured Product Label

CYSTEAMINE

Side effects:38
Source:FDA Structured Product Label

CYSTEAMINE

Side effects:48
Source:FDA Structured Product Label

mercaptamine / mercaptamine bitartrate

Side effects:52
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label